Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Tyme Technologies Inc. (TYME)

1.22   0 (0%) 07-10 16:00
Open: 1.22 Pre. Close: 1.22
High: 1.25 Low: 1.21
Volume: 113,614 Market Cap: 153M
Tyme Technologies, Inc., a clinical-stage biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate, sarcoma, and lymphoma. The company also offers TYME-18, a CMBT compound that is in preclinical stage for the treatment of solid tumors. Tyme Technologies, Inc. has a research collaboration with NYU Langone Health to advance the development of treatments for patients with metastatic cancers, including pancreatic cancer, as well as with Mayo Clinic; and a strategic collaboration with Eagle Pharmaceuticals, Inc. to advance oral SM-88 for the treatment of patients with cancer. The company was formerly known as Global Group Enterprises Corp. Tyme Technologies, Inc. was founded in 2011 and is headquartered in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.251 - 1.257 1.257 - 1.262
Low: 1.196 - 1.203 1.203 - 1.209
Close: 1.21 - 1.22 1.22 - 1.23

Technical analysis

as of: 2020-07-10 4:32:59 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.69     One year: 1.87
Support: Support1: 1.20    Support2:
Resistance: Resistance1: 1.45    Resistance2: 1.60
Pivot: 1.33
Moving Average: MA(5): 1.26     MA(20): 1.33
MA(100): 1.29     MA(250): 1.29
MACD: MACD(12,26): -0.05     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 5.61     %D(3): 7.25
RSI: RSI(14): 41.18
52-week: High: 2.04  Low: 0.86  Change(%): -2.4
Average Vol(K): 3-Month: 37681  10-Days: 34939

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
TYME has closed above bottom band by 16.7%. Bollinger Bands are 15.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 10 Jul 2020
Tyme Technologies Announces Virtual 2020 Annual Meeting of Stockholders - Business Wire

Fri, 10 Jul 2020

Tue, 07 Jul 2020
Insider Sells Tyme Technologies Shares - Yahoo Finance

Fri, 26 Jun 2020
Have Insiders Sold Tyme Technologies, Inc. (NASDAQ:TYME) Shares Recently? – Simply Wall St News - NasdaqNewsFeed

Tue, 23 Jun 2020
Tyme Inc. (TYME) Highlights New Preclinical Data Showing Anti-Cancer Effect of Cancer Metabolism-Based Pipeline Candidate, TYME-18 -

Tue, 23 Jun 2020
TYME-18 Demonstrates Anti-Cancer Effect in New Preclinical Data Presented at AACR 2020 - Business Wire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 126
Shares Float (M) 55
% Held by Insiders 55.58
% Held by Institutions 11.76
Shares Short (K) 4,090
Shares Short P. Month (K) 4,490

Stock Financials

EPS -0.192
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.150
Profit Margin
Operating Margin
Return on Assets (ttm) -68.5
Return on Equity (ttm) -153.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.205
Qtrly Earnings Growth
Operating Cash Flow (M) -20
Levered Free Cash Flow (M) -10

Stock Valuations

PE Ratio -6.35
PEG Ratio
Price to Book value 8.13
Price to Sales
Price to Cash Flow -7.84

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.